SA
Go ProLog In
ICL
OverviewIntelligenceChart
Next earnings: Aug 5, 2026 · Before open
Signal
Bearish Setup1!1↓
Price
1↓
Move↓-2.44%Negative session
Volume
1→
Volume→0.5× avgNormal activity
Technical
1→
RSI↑RSI 78Overbought
PRICE
Prev Close
6.57
Open
6.39
Day Range6.35 – 6.47
6.35
6.47
52W Range4.76 – 7.35
4.76
7.35
64% of range
VOLUME & SIZE
Avg Volume
1.7M
FUNDAMENTALS
P/E Ratio
30.5x
EPS (TTM)
—
Div Yield
0.30%
Beta
0.84
Market-like
Performance
1D↓
-3.74%
5D
+2.58%
1M↑
+23.40%
3M
+14.57%
6M
+20.24%
YTD
+14.97%
1Y
-3.60%
Best: 1M (+23.40%)Worst: 1D (-3.74%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +8% YoY
Valuation
EXPENSIVE
P/E 31x vs ~20x sector
Health
MODERATE
CR 1.4 · FCF $0.21/sh
Lean Bullish
Key MetricsTTM
Market Cap$8.23B
Revenue TTM$7.41B
Net Income TTM$261.00M
Free Cash Flow$264.95M
Gross Margin30.4%
Net Margin3.5%
Operating Margin10.2%
Return on Equity4.3%
Return on Assets2.0%
Debt / Equity0.52
Current Ratio1.38
EPS TTM$0.20
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong2 watch3 concern
32/100
Liquidity
1.38Watch
Leverage
0.52Strong
Coverage
2.5xWatch
ROE
4.3%Concern
ROIC
4.5%Concern
Cash
$291MConcern
ANALYST COVERAGE4 analysts
HOLD
▼ -4.1%downside to target
Hold
4100%
0 Buy (0%)4 Hold (100%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
8/10
Technicals
●
RSI RangeRSI 78 — Overbought, caution
~
Volume
●
Volume FlowAccumulation — institutional buying
✓
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusHold
~
●
LiquidityCurrent Ratio 1.38
~
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 28, 2026
In 104 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendDeath Cross · 50D trails 200D by 1.6%

+17.8% vs SMA 50 · +15.9% vs SMA 200

Momentum

RSI78.2
Overbought — pullback risk
MACD+0.36
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$7.35+14.7%
Current
$6.41
EMA 50
$5.73-10.5%
EMA 200
$5.54-13.6%
52W Low
$4.76-25.7%
52-Week RangeMid-range
$4.7664th %ile$7.35
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:4
Dist days:0
Edge:+4 acc
Volume Context
Avg Vol (50D)1.7M
Recent Vol (5D)
1.8M+3%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Full estimates →

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$7.0B
$6.9B–$7.1B
—$0.33—
±2%
Moderate3
FY2024
$6.9B
$6.9B–$7.0B
▼ -1.4%$0.39▲ +18.1%
±8%
Moderate4
FY2025
$7.2B
$7.1B–$7.2B
▲ +3.4%$0.36▼ -8.4%
±2%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryICL
Last 8Q
+11.8%avg beat
Beat 6 of 8 quarters↑ Estimates rising
+11%
Q3'24
+38%
Q4'24
—
Q1'25
+12%
Q2'25
+12%
Q3'25
+11%
Q4'25
—
Q1'26
+10%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
BarclaysOverweight
Nov 14
UPGRADE
Financials
Dividends0.03% yield
3 yrs of payments
Annual Yield0.03%
Quarterly Div.$0.0400
Est. Annual / Share$0.16
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
MEITAV INVESTMENT HOUSE LTD
29.8M▲
2
Clal Insurance Enterprises Holdings Ltd
22.0M▲
3
Y.D. More Investments Ltd
19.6M▲
4
Phoenix Holdings Ltd.
15.3M▼
5
MORGAN STANLEY
7.5M▲
6
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD
6.5M▲
7
VANGUARD FIDUCIARY TRUST CO
6.4M▲
8
BlackRock, Inc.
4.5M▼
News & Activity

ICL News

19 articles · 4h ago

About

ICL Group Ltd. is a multi-national manufacturing concern that develops, produces and markets fertilizers, metals and other special-purpose chemical products. ICL serves primarily three markets: agriculture, food and engineered materials.

CEO
Raviv Zoller
Country
Israel
Website
icl-group.com ↗
Advocate Lilach Geva-HarelDeputy CEO
Anantha N. DesikanExecutive Vice President and Chief Innovation & Technology Officer
Ido LilianExecutive Vice President of ICL Global CAPEX
Peers— —(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
ICL◀
$6.41-3.74%$8.3B31.4+456.1%316.0%1500
TSM
$404.35-3.20%$2.1T30.5+3296.8%4510.0%1500
BABA
$132.58-6.05%$307.9B20.7-44.8%1012.0%1500
HSBC
$88.38-2.58%$303.7B13.6+318.8%1510.7%1500
NVS
$148.08-1.13%$282.6B21.0+597.3%2564.4%1500
AZN
$181.58-1.83%$281.6B26.9+862.9%1745.9%1500
RY
$183.40-0.23%$256.1B16.8+213.3%1482.4%1500
Sector avg—-2.68%—23.0+814.3%1877.3%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance